{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiex7dehfx6tplqalemjleqeraufktf4ooute3zakk7h7rhuivbzsu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjkoeaix2722"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig6fwlvw7c3lnedejklo4rbm6wz6gve2qafm5cuj7pd4dlwzc7xu4"
    },
    "mimeType": "image/jpeg",
    "size": 379811
  },
  "path": "/news/2026-04-psychedelic-mental-health-trials-reliable.html",
  "publishedAt": "2026-04-15T15:40:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Drug trials generally involve comparing a treatment with a nonactive, placebo version, an approach called \"blinding\" because patients must be \"blind\" as to which they've received for the trial to work. Canadian researchers say this is a huge issue for studies of psychedelic therapies because it's fairly obvious to patients whether they've been given a psychedelic or a placebo.",
  "title": "Why psychedelic mental health trials may be less reliable than they appear"
}